July 1, 2026 · Phase 2 readout
ALMS Phase 2 readout: a negative outcome, -5.3%
-5.3%ALUMIS INC. (ALMS) →
On July 1, 2026, ESK-001 — ALUMIS INC. (Plaque Psoriasis) reached its Phase 2 readout. The result was a negative outcome, and the stock moved -5.3% in the window around the event. It had already run +29.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$28.14
1d before
$26.64
Event day
$26.50
1d after
$27.27
5d after
Our prediction vs. the result
CatalystAlert called this one up (+6.3% expected); the stock actually moved -5.3%. Model confidence at the time: 60%.
See the full scored track recordPre-catalyst setup
+29.9%
30-day run-up
7096%
30-day volatility
1.5×
volume spike